AC Immune SA Form 6-K Summary
Business Context and Reporting Period
This Form 6-K is a report of a foreign private issuer filed by AC Immune SA for the month of August 2021. The filing was submitted on August 31, 2021, and is signed by CEO Andrea Pfeifer and CFO Joerg Hornstein. The registrant files annual reports under Form 20-F.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a cover sheet referencing an external press release rather than containing a financial statement.
Material Changes
The filing text does not provide data to compare against prior periods. The document references Exhibit 99.1, a press release dated August 31, 2021, which likely contains the material information, but the content of that press release is not included in the provided text.
Guidance, Outlook, and Risks
The filing text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These details are expected to be found in the referenced press release (Exhibit 99.1).
Key Facts for Investor Verification
- Verify the content of the press release dated August 31, 2021 (Exhibit 99.1), as the financial and operational details are not in this cover document.
- Confirm the company's status as a foreign private issuer filing under Form 20-F.
- Note that no financial metrics are disclosed within the text of this specific Form 6-K.